These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 9750972

  • 1. Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers.
    Koszycki D, Zacharko RM, Le Mellédo JM, Bradwejn J.
    Depress Anxiety; 1998; 8(1):1-7. PubMed ID: 9750972
    [Abstract] [Full Text] [Related]

  • 2. Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4.
    Eser D, Leicht G, Baghai T, Pogarell O, Schüle C, Karch S, Nothdurfter C, Rupprecht R, Mulert C.
    J Psychiatr Res; 2009 Jan; 43(4):393-400. PubMed ID: 18534623
    [Abstract] [Full Text] [Related]

  • 3. Effects of CCK-tetrapeptide in patients with social phobia and obsessive-compulsive disorder.
    Katzman MA, Koszycki D, Bradwejn J.
    Depress Anxiety; 2004 Jan; 20(2):51-8. PubMed ID: 15390214
    [Abstract] [Full Text] [Related]

  • 4. Neurohormonal responses to cholecystokinin tetrapeptide: a comparison of younger and older healthy subjects.
    Flint AJ, Koszycki D, Bradwejn J, Vaccarino FJ.
    Psychoneuroendocrinology; 2000 Aug; 25(6):633-47. PubMed ID: 10840174
    [Abstract] [Full Text] [Related]

  • 5. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.
    Schunck T, Mathis A, Erb G, Namer IJ, Hode Y, Demazières A, Luthringer R.
    J Psychopharmacol; 2011 Jan; 25(1):52-9. PubMed ID: 20498136
    [Abstract] [Full Text] [Related]

  • 6. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.
    Maron E, Tõru I, Tasa G, Must A, Toover E, Lang A, Vasar V, Shlik J.
    Neurosci Lett; 2008 Dec 03; 446(2-3):88-92. PubMed ID: 18832011
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study.
    Eser D, Schüle C, Baghai T, Floesser A, Krebs-Brown A, Enunwa M, de la Motte S, Engel R, Kucher K, Rupprecht R.
    Psychopharmacology (Berl); 2007 Jul 03; 192(4):479-87. PubMed ID: 17318504
    [Abstract] [Full Text] [Related]

  • 8. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone.
    Demiralay C, Jahn H, Kellner M, Yassouridis A, Wiedemann K.
    World J Biol Psychiatry; 2012 Oct 03; 13(7):526-34. PubMed ID: 22111662
    [Abstract] [Full Text] [Related]

  • 9. CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects.
    Maron E, Tõru I, Mäemets K, Sepp S, Vasar V, Shlik J, Zharkovsky A.
    J Psychopharmacol; 2009 Jun 03; 23(4):460-4. PubMed ID: 18562429
    [Abstract] [Full Text] [Related]

  • 10. Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers.
    Tõru I, Aluoja A, Võhma U, Raag M, Vasar V, Maron E, Shlik J.
    Psychiatry Res; 2010 Jul 30; 178(2):342-7. PubMed ID: 20471107
    [Abstract] [Full Text] [Related]

  • 11. Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers.
    Zwanzger P, Baghai TC, Schuele C, Ströhle A, Padberg F, Kathmann N, Schwarz M, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2001 Nov 30; 25(5):699-703. PubMed ID: 11682253
    [Abstract] [Full Text] [Related]

  • 12. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
    Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K.
    Depress Anxiety; 2006 Nov 30; 23(3):139-44. PubMed ID: 16470820
    [Abstract] [Full Text] [Related]

  • 13. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
    Ströhle A, Holsboer F, Rupprecht R.
    Neuropsychopharmacology; 2000 Mar 30; 22(3):251-6. PubMed ID: 10693152
    [Abstract] [Full Text] [Related]

  • 14. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).
    Zwanzger P, Eser D, Völkel N, Baghai TC, Möller HJ, Rupprecht R, Padberg F.
    Int J Neuropsychopharmacol; 2007 Apr 30; 10(2):285-9. PubMed ID: 16817979
    [Abstract] [Full Text] [Related]

  • 15. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P, Eser D, Aicher S, Schüle C, Baghai TC, Padberg F, Ella R, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2003 May 30; 28(5):979-84. PubMed ID: 12700707
    [Abstract] [Full Text] [Related]

  • 16. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers.
    Eser D, di Michele F, Zwanzger P, Pasini A, Baghai TC, Schüle C, Rupprecht R, Romeo E.
    Neuropsychopharmacology; 2005 Jan 30; 30(1):192-5. PubMed ID: 15467707
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity to cholecystokinin-tetrapeptide in major depression.
    Koszycki D, Copen J, Bradwejn J.
    J Affect Disord; 2004 Jun 30; 80(2-3):285-90. PubMed ID: 15207943
    [Abstract] [Full Text] [Related]

  • 18. Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholism.
    George DT, Nutt DJ, Rawlings RR, Phillips MJ, Eckardt MJ, Potter WZ, Linnoila M.
    Biol Psychiatry; 1995 Jan 15; 37(2):112-9. PubMed ID: 7718674
    [Abstract] [Full Text] [Related]

  • 19. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety.
    Schunck T, Erb G, Mathis A, Gilles C, Namer IJ, Hode Y, Demaziere A, Luthringer R, Macher JP.
    Neuroimage; 2006 Jul 01; 31(3):1197-208. PubMed ID: 16600640
    [Abstract] [Full Text] [Related]

  • 20. Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers.
    Bradwejn J, Koszycki D, Paradis M, Reece P, Hinton J, Sedman A.
    Biol Psychiatry; 1995 Dec 01; 38(11):742-6. PubMed ID: 8580227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.